Novavax Inc. on Aug. 5 again delayed the company’s timeline for seeking U.S. authorization for its two-dose Covid-19 vaccine, but expects to become a major distributor to lower and middle-income countries this year.
South Korean drugmaker Daewoong Pharmaceutical Co. Ltd. received regulatory approval for Phase 1 clinical trials of the company’s anti-parasitic niclosamide drug to treat Covid-19 patients.
Russia became the first country to grant regulatory approval to a Covid-19 vaccine, after less than two months of human testing.
China accused the United States of whipping up panic over a fast-spreading coronavirus with travel restrictions and evacuations as Chinese stocks plunged on the first day back from the extended Lunar New Year holiday.
The Philippines is considering re-introducing a dengue vaccine whose use was halted because of links to the deaths of several children, as authorities battle to contain a dengue outbreak that has killed more than 450 people in 2019.
The United States recorded 41 new measles cases last week, bringing 2019’s total number of cases to 981 in the worst outbreak of the disease since 1992, federal health officials said.
The U.S. FDA gave Sanofi SA’s dengue vaccine Dengvaxia a very narrow approval as the company continues to suffer from evidence that its vaccine can cause severe infections in some people.
The Philippine Department of Justice has found probable cause to indict officials from French drugmaker Sanofi and former and current Philippine health officials over 10 deaths the department said were linked to use of a dengue vaccine.
The number of people dying from heatwaves is likely to rise sharply in some regions by 2080 if policymakers fail to take mitigating steps in climate and health policies, according to the results of a study.
Sanofi forecast a return to profit growth in 2018, but the company’s shares fell as analysts had hoped for a bigger boost from recent deals and a revamped drugs pipeline.